Metropolitan Life Insurance Company (MetLife)’s Tourmaline Bio TRML Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-162	Closed	-$7.29K	–	2355
2022 Q2	$7.29K	Buy	+162	New	+$7.29K	﹤0.01%	2329
2022 Q1	–	Sell	-723	Closed	-$111K	–	2667
2021 Q4	$111K	Buy	+723	New	+$111K	﹤0.01%	2421